source avatarForesight News

Share
Share IconShare IconShare IconShare IconShare IconShare IconCopy

**[Abra Aims for IPO in Q1 Next Year, Launches Synthetic Asset Platform AbraFi and Synthetic Dollar USDAF on Solana]** Foresight News reports on-site that Bill Barhydt, CEO of crypto financial services company @AbraGlobal, announced at the Solana Breakpoint conference the launch of AbraFi, a synthetic asset tokenization platform built on Solana. AbraFi will be released in the form of a DAO (Decentralized Autonomous Organization) and will not be owned by Abra Inc. Governance token holders of AFI will receive a large portion of the protocol's revenue distribution and have governance rights over product mechanisms. The first product of AbraFi is the synthetic dollar USDAF. This is a digital dollar fully backed by crypto assets such as SOL, Tether, and Circle, and maintained with delta hedging through DeFi protocols to preserve its peg. The platform will also release a stakable version of USDAF, called SDAF, which will generate yield. AbraFi is currently in its seed funding round, with committed funds already reaching tens of millions of dollars, and it is expected to surpass $100 million by mid-December. The platform is scheduled to officially launch around January 1. Additionally, Bill Barhydt revealed that Abra's core asset management business is experiencing strong growth, and the company is actively considering going public through an IPO (Initial Public Offering) in the first quarter of next year.

No.0 picture
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.